author-photo

Cibo Huang

55

Papers

554

Citations

Citation Trend

Filter By

Papers (37) Sort By

Journal Conference Others

Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.

2021 BMC Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Efficacy of Cortex Daphnes (Zushima) Patch in Patients With Symptomatic Knee Osteoarthritis: A Multicenter Non-Inferiority Randomized Controlled Clinical Trial

2021 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up

2021
Show All
- Source
- Cite
- Save
Citations (0)
2018 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis

2021
Show All
- Source
- Cite
- Save
Citations (2)
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.

2021 Clinical Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial.

2020 Trials
Show All
- Source
- Cite
- Save
Citations (1)
Identification and Functional Enrichment Analysis of Differentially Expressed Genes in Osteoarthritis

2020
Show All
- Source
- Cite
- Save
Citations (0)
Erratum to development and formulation of the classification criteria for osteoarthritis

2020 Annals of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Risk factors of restenosis of percutaneous transluminal angioplasty of Takayasu arteritis

2020 Chinese Journal of General Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial

2020 BioDrugs
Show All
- Source
- Cite
- Save
Citations (8)